Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Prescribing Patterns for Treatment of Mycobacterium avium Complex and M. xenopi Pulmonary Disease in Ontario, Canada, 2001-2013.

Brode SK, Chung H, Campitelli MA, Kwong JC, Marchand-Austin A, Winthrop KL, Jamieson FB, Marras TK.

Emerg Infect Dis. 2019 Jul;25(7). doi: 10.3201/eid2507.181817.

2.

Safety and effectiveness of low-dose amikacin in nontuberculous mycobacterial pulmonary disease treated in Toronto, Canada.

Aznar ML, Marras TK, Elshal AS, Mehrabi M, Brode SK.

BMC Pharmacol Toxicol. 2019 Jun 3;20(1):37. doi: 10.1186/s40360-019-0302-1.

3.

Radiologic types of Mycobacterium xenopi pulmonary disease: different patients with similar short-term outcomes.

Hirama T, Brode SK, Marras TK.

Eur J Clin Microbiol Infect Dis. 2019 Feb;38(2):373-381. doi: 10.1007/s10096-018-3437-x. Epub 2018 Dec 14.

PMID:
30552538
4.

Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis.

Collaborative Group for the Meta-Analysis of Individual Patient Data in MDR-TB treatment–2017, Ahmad N, Ahuja SD, Akkerman OW, Alffenaar JC, Anderson LF, Baghaei P, Bang D, Barry PM, Bastos ML, Behera D, Benedetti A, Bisson GP, Boeree MJ, Bonnet M, Brode SK, Brust JCM, Cai Y, Caumes E, Cegielski JP, Centis R, Chan PC, Chan ED, Chang KC, Charles M, Cirule A, Dalcolmo MP, D'Ambrosio L, de Vries G, Dheda K, Esmail A, Flood J, Fox GJ, Fréchet-Jachym M, Fregona G, Gayoso R, Gegia M, Gler MT, Gu S, Guglielmetti L, Holtz TH, Hughes J, Isaakidis P, Jarlsberg L, Kempker RR, Keshavjee S, Khan FA, Kipiani M, Koenig SP, Koh WJ, Kritski A, Kuksa L, Kvasnovsky CL, Kwak N, Lan Z, Lange C, Laniado-Laborín R, Lee M, Leimane V, Leung CC, Leung EC, Li PZ, Lowenthal P, Maciel EL, Marks SM, Mase S, Mbuagbaw L, Migliori GB, Milanov V, Miller AC, Mitnick CD, Modongo C, Mohr E, Monedero I, Nahid P, Ndjeka N, O'Donnell MR, Padayatchi N, Palmero D, Pape JW, Podewils LJ, Reynolds I, Riekstina V, Robert J, Rodriguez M, Seaworth B, Seung KJ, Schnippel K, Shim TS, Singla R, Smith SE, Sotgiu G, Sukhbaatar G, Tabarsi P, Tiberi S, Trajman A, Trieu L, Udwadia ZF, van der Werf TS, Veziris N, Viiklepp P, Vilbrun SC, Walsh K, Westenhouse J, Yew WW, Yim JJ, Zetola NM, Zignol M, Menzies D.

Lancet. 2018 Sep 8;392(10150):821-834. doi: 10.1016/S0140-6736(18)31644-1. Review.

5.

Adjuvant lung resection in the management of nontuberculous mycobacterial lung infection: A retrospective matched cohort study.

Aznar ML, Zubrinic M, Siemienowicz M, Hashimoto K, Brode SK, Mehrabi M, Patsios D, Keshavjee S, Marras TK.

Respir Med. 2018 Sep;142:1-6. doi: 10.1016/j.rmed.2018.07.003. Epub 2018 Jul 9.

PMID:
30170795
6.

Characteristics, treatment and outcomes of nontuberculous mycobacterial pulmonary disease after allogeneic haematopoietic stem cell transplant.

Hirama T, Brode SK, Beswick J, Law AD, Lam W, Michelis FV, Thyagu S, Viswabandya A, Lipton JH, Messner HA, Kim DDH, Marras TK.

Eur Respir J. 2018 May 3;51(5). pii: 1702330. doi: 10.1183/13993003.02330-2017. Print 2018 May. No abstract available.

7.

Mycobacterium xenopi Genotype Associated with Clinical Phenotype in Lung Disease.

Hirama T, Marchand-Austin A, Ma J, Alexander DC, Brode SK, Marras TK, Jamieson FB.

Lung. 2018 Apr;196(2):213-217. doi: 10.1007/s00408-018-0087-9. Epub 2018 Jan 18.

PMID:
29349535
8.

Pulmonary versus Nonpulmonary Nontuberculous Mycobacteria, Ontario, Canada.

Brode SK, Marchand-Austin A, Jamieson FB, Marras TK.

Emerg Infect Dis. 2017 Nov;23(11):1898-1901. doi: 10.3201/eid2311.170959.

9.

The risk of mycobacterial infections associated with inhaled corticosteroid use.

Brode SK, Campitelli MA, Kwong JC, Lu H, Marchand-Austin A, Gershon AS, Jamieson FB, Marras TK.

Eur Respir J. 2017 Sep 20;50(3). pii: 1700037. doi: 10.1183/13993003.00037-2017. Print 2017 Sep.

10.

Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.

Marras TK, Campitelli MA, Lu H, Chung H, Brode SK, Marchand-Austin A, Winthrop KL, Gershon AS, Kwong JC, Jamieson FB.

Emerg Infect Dis. 2017 Mar;23(3):468-476. doi: 10.3201/eid2303.161927.

12.

Risk of nontuberculous mycobacterial pulmonary disease with obstructive lung disease.

Marras TK, Campitelli MA, Kwong JC, Lu H, Brode SK, Marchand-Austin A, Gershon AS, Jamieson FB.

Eur Respir J. 2016 Sep;48(3):928-31. doi: 10.1183/13993003.00033-2016. Epub 2016 Jun 10. No abstract available.

13.

Health-related quality of life, comorbidities and mortality in pulmonary nontuberculous mycobacterial infections: A systematic review.

Yeung MW, Khoo E, Brode SK, Jamieson FB, Kamiya H, Kwong JC, Macdonald L, Marras TK, Morimoto K, Sander B.

Respirology. 2016 Aug;21(6):1015-25. doi: 10.1111/resp.12767. Epub 2016 Mar 23. Review.

14.

Increased risk of mycobacterial infections associated with anti-rheumatic medications.

Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK.

Thorax. 2015 Jul;70(7):677-82. doi: 10.1136/thoraxjnl-2014-206470. Epub 2015 Apr 24.

PMID:
25911222
15.

Multidrug-resistant tuberculosis: Treatment and outcomes of 93 patients.

Brode SK, Varadi R, McNamee J, Malek N, Stewart S, Jamieson FB, Avendano M.

Can Respir J. 2015 Mar-Apr;22(2):97-102. Epub 2014 Dec 10.

16.

The epidemiologic relationship between tuberculosis and non-tuberculous mycobacterial disease: a systematic review.

Brode SK, Daley CL, Marras TK.

Int J Tuberc Lung Dis. 2014 Nov;18(11):1370-7. doi: 10.5588/ijtld.14.0120. Review.

PMID:
25299873
17.

Multilocus sequence typing of Mycobacterium xenopi.

Alexander DC, Marras TK, Ma JH, Mirza S, Liu D, Kus JV, Soualhine H, Escuyer V, Warshauer D, Brode SK, Farrell DJ, Jamieson FB.

J Clin Microbiol. 2014 Nov;52(11):3973-7. doi: 10.1128/JCM.01601-14. Epub 2014 Sep 10.

18.

Risk of mycobacterial infections associated with rheumatoid arthritis in Ontario, Canada.

Brode SK, Jamieson FB, Ng R, Campitelli MA, Kwong JC, Paterson JM, Li P, Marchand-Austin A, Bombardier C, Marras TK.

Chest. 2014 Sep;146(3):563-572. doi: 10.1378/chest.13-2058.

PMID:
24384637
19.

Alpha-1 antitrypsin deficiency: a commonly overlooked cause of lung disease.

Brode SK, Ling SC, Chapman KR.

CMAJ. 2012 Sep 4;184(12):1365-71. doi: 10.1503/cmaj.111749. Epub 2012 Jul 3. Review. No abstract available.

20.

Dual therapy in IPAH and SSc-PAH. A qualitative systematic review.

Johnson SR, Brode SK, Mielniczuk LM, Granton JT.

Respir Med. 2012 May;106(5):730-9. doi: 10.1016/j.rmed.2011.12.018. Epub 2012 Feb 25. Review.

Supplemental Content

Loading ...
Support Center